(Q33787614)

29 July 2017

1 reference

title

Therapeutic strategies for allergic diseases (English)

1 reference

29 July 2017

Barnes PJ

1

1 reference

PubMed ID

10586893

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

29 July 2017

1 reference

29 July 2017

402

1 reference

29 July 2017

B31-8

1 reference

29 July 2017

6760 Suppl

1 reference

https://scigraph.springernature.com/pub.10.1038/35037026

29 July 2017

0 references

cites work

Efficacy and safety of inhaled corticosteroids. New developments

1 reference

Effect of corticosteroids on nasal blockage in rhinitis measured by objective methods

21 January 2018

1 reference

Treatment of asthma with drugs modifying the leukotriene pathway.

21 January 2018

1 reference

Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription

21 January 2018

1 reference

Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis

21 January 2018

1 reference

Nitric oxide and airway disease

21 January 2018

1 reference

Is endothelin-1 a mediator in asthma?

21 January 2018

1 reference

Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep.

21 January 2018

1 reference

21 January 2018

1 reference

Biology of interleukin-5 and its relevance to allergic disease

21 January 2018

1 reference

Interleukin-13: central mediator of allergic asthma

21 January 2018

1 reference

Interleukin-4 and interleukin-13: their similarities and discrepancies

21 January 2018

1 reference

Chemokines--chemotactic cytokines that mediate inflammation

21 January 2018

1 reference

Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody

21 January 2018

1 reference

The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3

21 January 2018

1 reference

Inhibitory cytokines in asthma

21 January 2018

1 reference

Effect of interleukin-1 receptor antagonist on antigen-induced pulmonary responses in guinea pigs

21 January 2018

1 reference

IL-10: a potential therapy for allergic inflammation?

21 January 2018

1 reference

Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group

21 January 2018

1 reference

Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.

21 January 2018

1 reference

Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.

21 January 2018

1 reference

The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses

21 January 2018

1 reference

Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice

21 January 2018

1 reference

Phosphodiesterase isozymes: molecular targets for novel antiasthma agents

21 January 2018

1 reference

The effect of a novel orally active selective PDE4 isoenzyme inhibitor (CDP840) on allergen-induced responses in asthmatic subjects

21 January 2018

1 reference

Subtypes of the type 4 cAMP phosphodiesterases: structure, regulation and selective inhibition

21 January 2018

1 reference

Induction of phosphodiesterases 3B, 4A4, 4D1, 4D2, and 4D3 in Jurkat T-cells and in human peripheral blood T-lymphocytes by 8-bromo-cAMP and Gs-coupled receptor agonists. Potential role in beta2-adrenoreceptor desensitization.

21 January 2018

1 reference

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

21 January 2018

1 reference

Transcription factors and asthma

21 January 2018

1 reference

Mitogen-activated protein kinase cascades as regulators of stress responses.

21 January 2018

1 reference

Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils

21 January 2018

1 reference

Cyclosporin A in asthma therapy: a pharmacological rationale

21 January 2018

1 reference

New immunosuppressive drugs: mechanistic insights and potential therapeutic advances

21 January 2018

1 reference

Cell adhesion molecules in asthma: homing, activation, and airway remodeling

21 January 2018

1 reference

A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo

21 January 2018

1 reference

Contribution of intercellular-adhesion molecule-1 in allergen-induced airway hyperresponsiveness and inflammation in sensitised brown-Norway rats.

21 January 2018

1 reference

Intracellular single-chain antibody inhibits integrin VLA-4 maturation and function

21 January 2018

1 reference

Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responses

21 January 2018

1 reference

Inhibition of volume-activated chloride currents in endothelial cells by chromones

21 January 2018

1 reference

Ca2+ and phorbol ester effect on the mast cell phosphoprotein induced by cromolyn

21 January 2018

1 reference

Requirement of CD28-CD86 costimulation for allergen-specific T cell proliferation and cytokine expression.

21 January 2018

1 reference

Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma

21 January 2018

1 reference

Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene

21 January 2018

1 reference

Reversibility of T helper 1 and 2 populations is lost after long-term stimulation

21 January 2018

1 reference

The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics

21 January 2018

1 reference

Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody

21 January 2018

1 reference

Long-term clinical efficacy of grass-pollen immunotherapy

21 January 2018

1 reference

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

21 January 2018

1 reference

Induction of non-responsiveness in human allergen-specific type 2 T helper cells

21 January 2018

1 reference

Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions

21 January 2018

1 reference

The inverse association between tuberculin responses and atopic disorder.

21 January 2018

1 reference

BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model.

21 January 2018

1 reference

Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae.

21 January 2018

1 reference

Immune and clinical impact of Lactobacillus acidophilus on asthma.

21 January 2018

1 reference

Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions

21 January 2018

1 reference

DNA antisense therapy for asthma in an animal model

21 January 2018

1 reference

21 January 2018

1 reference

7 January 2021

A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients

1 reference

7 January 2021

Anti-inflammatory actions of glucocorticoids: molecular mechanisms

1 reference

7 January 2021

Effects of antihistamines in adult asthma: a meta-analysis of clinical trials

1 reference

7 January 2021

Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics

1 reference

7 January 2021

IL-10: evolving concepts

1 reference

7 January 2021

STAT6: an intracellular target for the inhibition of allergic disease

1 reference

7 January 2021

Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases

1 reference

7 January 2021

Interleukin-10 regulation in normal subjects and patients with asthma

1 reference

7 January 2021

Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma

1 reference

7 January 2021

The effects of nebulized recombinant interferon-gamma in asthmatic airways

1 reference

7 January 2021

The kinetics of change in cytokine production by CD4 T cells during conventional allergen immunotherapy

1 reference

7 January 2021

Src family-selective tyrosine kinase inhibitor, PP1, inhibits both Fc epsilonRI- and Thy-1-mediated activation of rat basophilic leukemia cells

1 reference

7 January 2021

Trial of cyclosporin in corticosteroid-dependent chronic severe asthma

1 reference

7 January 2021

Treatment of steroid-dependent bronchial asthma with cyclosporin

1 reference

7 January 2021

Topical tacrolimus (FK 506): a new milestone in the management of atopic dermatitis

1 reference

7 January 2021

Selectin blockade prevents antigen-induced late bronchial responses and airway hyperresponsiveness in allergic sheep

1 reference

7 January 2021

Antagonism of selectin-dependent adhesion of human eosinophils and neutrophils by glycomimetics and oligosaccharide compounds

1 reference

7 January 2021

Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide

1 reference

7 January 2021

Anti-CD86 (B7.2) treatment abolishes allergic airway hyperresponsiveness in mice

1 reference

7 January 2021

Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murine model of allergic asthma

1 reference

7 January 2021

The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects

1 reference

7 January 2021

Treatment of allergic airways disease with anti-IgE

1 reference

7 January 2021

Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization

1 reference

7 January 2021

Treatment of cat allergy with T-cell reactive peptides

1 reference

7 January 2021

Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria

1 reference

7 January 2021

Identifiers

DOI

10.1038/35037026

1 reference

PubMed ID

10586893

Dimensions Publication ID

29 July 2017

0 references

1 reference

PubMed ID

10586893